| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/25/2002 | US6410708 Nucleotide sequences coding preferential protein for use in the diagnosis and treatment of inflammation, cancer and inflammatory bowel disease |
| 06/25/2002 | US6410704 Nucleotide sequences coding enzymatic polypeptide for use in treatment of viral disease |
| 06/25/2002 | US6410697 Isolating mammalian glycoprotein; obtain sample with glycoprotein, incubate with antibody, apply solution to matrix, elute and recover mammalian glycoprotein |
| 06/25/2002 | US6410696 Cyclosporin immunoassay |
| 06/25/2002 | US6410692 Separating liquid sample; incubate sample with polypeptide, incubate macromolecule-polypeptide complex with second binding particle, detect complex |
| 06/25/2002 | US6410691 Monoclonal antibody for use in diagnosis and treatment of immunlogical defects, cancer and rheumatic diseases |
| 06/25/2002 | US6410690 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 06/25/2002 | US6410688 Def1 |
| 06/25/2002 | US6410508 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 06/25/2002 | US6410507 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 06/25/2002 | US6410319 CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies |
| 06/25/2002 | US6410318 Antibodies directed against binding-associated epitopes |
| 06/25/2002 | US6410299 Attenuated forms of bovine viral diarrhea virus |
| 06/25/2002 | US6410289 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 06/25/2002 | US6410271 Gpreparing preferential yeast expression vectors; obtain yeast vector, transform yeast with nucleotide sequences, insert preferential nucleotide sequences into vector, recover vector |
| 06/25/2002 | US6410270 Process for the preparation of recombinant proteins in E. coli by high cell density fermentation |
| 06/25/2002 | US6410264 Pichia pastoris gene sequences and methods for their use |
| 06/25/2002 | US6410263 Histidine kinase |
| 06/25/2002 | US6410261 CIITA-interacting proteins and methods of use therefor |
| 06/25/2002 | US6410247 Nuclear matrix protein fluid assay |
| 06/25/2002 | US6410246 Highly diverse library of yeast expression vectors |
| 06/25/2002 | US6410240 Complexing |
| 06/25/2002 | US6410238 Hybrid nucleic acids; cancer diagnosis |
| 06/25/2002 | US6410232 Molecules of the follistatin-related protein family and uses thereof |
| 06/25/2002 | US6410226 Quantitative analysis; calibration |
| 06/25/2002 | US6410032 Attenuated forms of bovine viral diarrhea virus |
| 06/25/2002 | US6410024 Epitopes of shigella like toxin and their use as vaccine and in diagnosis |
| 06/25/2002 | US6410022 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 06/25/2002 | US6410020 Monoclonal antibody reactive to human CETP and assay method for human CETP |
| 06/25/2002 | US6410019 Topical administration of immunoglobulins brings about remission of inflammatory process without causing any toxic or unwanted side effects |
| 06/25/2002 | US6410009 Pharmaceutical composition for treating hepatitis B virus (HBV) infection |
| 06/25/2002 | US6410008 Chimeric IL-10 proteins and uses thereof |
| 06/25/2002 | CA2085881C Dna encoding mammalian phosphodiesterases |
| 06/25/2002 | CA2036814C Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
| 06/25/2002 | CA2006412C Eimeria tenella vaccine |
| 06/23/2002 | WO2002040654A2 A human serpin secreted from lymphoid cells lsi-01 |
| 06/23/2002 | CA2429179A1 Polynucleotide encoding a novel human serpin secreted from lymphoid cells lsi-01 |
| 06/20/2002 | WO2002048675A2 Improved compositions and methods for producing antibodies to low molecular weight analytes |
| 06/20/2002 | WO2002048405A2 Non-invasive method for detecting target rna |
| 06/20/2002 | WO2002048395A1 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 06/20/2002 | WO2002048388A2 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 06/20/2002 | WO2002048370A2 Compositions and methods relating to colon specific genes and proteins |
| 06/20/2002 | WO2002048368A2 Proteins associated with cell growth, differentiation, and death |
| 06/20/2002 | WO2002048366A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | WO2002048365A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | WO2002048363A2 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 06/20/2002 | WO2002048359A1 Magnetic particle membrane-specific protein |
| 06/20/2002 | WO2002048348A1 Novel gene existing in human leukocyte antigen domain |
| 06/20/2002 | WO2002048337A2 Secreted human proteins |
| 06/20/2002 | WO2002048335A2 Metal resistant plants and use for phytoremediation |
| 06/20/2002 | WO2002048334A2 P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereof |
| 06/20/2002 | WO2002048321A2 Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect |
| 06/20/2002 | WO2002048315A2 Monoclonal antibody probe for detection of adhesins associated with mature endospores of pasteuria spp. |
| 06/20/2002 | WO2002048193A2 Camelidae antibody arrays |
| 06/20/2002 | WO2002048188A1 Plasmodium aldolase polypeptides and nucleic acids |
| 06/20/2002 | WO2002048182A2 Interferon-alpha induced gene |
| 06/20/2002 | WO2002047730A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 06/20/2002 | WO2002047728A2 Treatment of posterior capsule opacification |
| 06/20/2002 | WO2002047721A1 Silensed anti-cd28 antibodies and use thereof |
| 06/20/2002 | WO2002047720A2 Treatment and prevention of ebv infection and ebv-associated disorders |
| 06/20/2002 | WO2002047534A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/20/2002 | WO2002047466A2 Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof |
| 06/20/2002 | WO2002032375A3 Uses of monoclonal antibody 8h9 |
| 06/20/2002 | WO2002028905A3 Human anti-cd40 antibodies |
| 06/20/2002 | WO2002022077A3 Compositions and methods for inhibition of hiv-1 infection |
| 06/20/2002 | WO2002016436A3 ANTIBODIES TO HUMAN IL-1$g(b) |
| 06/20/2002 | WO2002008291A3 Multi-specific reagent for selective stimulation of cell surface receptors |
| 06/20/2002 | WO2002003911A8 Prevention and treatment of alzheimer's disease |
| 06/20/2002 | WO2002000711A3 Ev-vegf nucleic acids and polypeptides and methods of use |
| 06/20/2002 | WO2001098358A3 Compositions for identification and isolation of stem cells |
| 06/20/2002 | WO2001094613A3 Methods and compounds for influencing beta3 integrin-dependent intracellular processes |
| 06/20/2002 | WO2001092876A3 Method for identifying compounds for modulating the activity of a tumour suppressor protein |
| 06/20/2002 | WO2001090194A3 Antibodies against particular forms of propsa and use thereof in immunoassays |
| 06/20/2002 | WO2001090191A3 ANTIBODIES CAPABLE TO SELECTIVELY DETECT PRION PrPSc ISOFORMS |
| 06/20/2002 | WO2001090152A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/20/2002 | WO2001085942A3 Cytoskeleton-associated proteins |
| 06/20/2002 | WO2001083559A3 Production and use of protein variants having modified immunogenecity |
| 06/20/2002 | WO2001083524A3 Rna metabolism proteins |
| 06/20/2002 | WO2001081417A3 Use of taci as an anti-tumor agent |
| 06/20/2002 | WO2001074904A3 G-protein coupled receptors and nucleic acids encoding same |
| 06/20/2002 | WO2001072830A3 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| 06/20/2002 | WO2001068851A3 Polypeptides and nucleic acids encoding same |
| 06/20/2002 | WO2001062298A3 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 06/20/2002 | WO2001060857A3 Compositions useful for regulating parkin gene activity |
| 06/20/2002 | WO2001053487A3 Human sperm specific lysozyme-like proteins |
| 06/20/2002 | WO2001051633A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/20/2002 | WO2001044445A8 Human lyases and associated proteins |
| 06/20/2002 | WO2000075333A9 Streptavidin expressed gene fusions and methods of use thereof |
| 06/20/2002 | WO2000061750A9 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
| 06/20/2002 | WO2000061596A8 50 human secreted proteins |
| 06/20/2002 | WO2000056774A9 Methods of using bioelastomers |
| 06/20/2002 | WO2000050596A9 14273 receptor, a novel g-protein coupled receptor |
| 06/20/2002 | US20020078473 Pesticides |
| 06/20/2002 | US20020077465 Nuceotide sequences coding enzymatic polypeptide for use in the treatment and prevention of inflammation, cancer, muuscle disorders and thrombosis |
| 06/20/2002 | US20020077460 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 06/20/2002 | US20020077458 Nucleotide sequences for use in the diagnosis, treatment and prevention of apoptosis defects |
| 06/20/2002 | US20020077454 Therapeutic pore-forming peptides |
| 06/20/2002 | US20020077309 For diagnosis, prognosis, evaluation of therapies and treatment of pancreatic disorders |
| 06/20/2002 | US20020077305 Genetic immunization with cationic lipids |
| 06/20/2002 | US20020077296 High-throughput screening method |